Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
3 drugs for “Advanced Melanoma”
Approved 1
- TebentafuspImmunocore Holdings plcAdvanced Melanoma
Phase 3 1
- BrenetafuspImmunocore Holdings plcAdvanced Melanoma
Phase 2/3 1
- EIK1001Eikon Therapeutics, Inc.Advanced Melanoma
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.